Seeking Alpha
View as an RSS Feed

Bret Jensen  

View Bret Jensen's Comments BY TICKER:
A, AA, AAPL, ABB, ABT, ABTL, ABX, ACLS, ACMP, ACTG, ACTV, ADBE, ADSK, AEP, AGCO, AGEN, AGU, AHH, AHT, AIG, AKS, ALJ, ALL, ALR, AMAT, AMGN, AMKR, AMTD, AMZG, AMZN, ANF, ANV, APA, APC, APL, ARCP, ARII, ARLP, ARO, ARP, ATRS, ATSG, ATVI, ATW, AU, AVGO, AVNR, AXAS, AXTI, AYR, AZN, BA, BAC, BAS, BAX, BBBY, BBEP, BBRY, BBT, BBW, BBY, BCEI, BGFV, BHI, BIDU, BIG, BIIB, BIOL, BK, BKCC, BKH, BKW, BLK, BMO, BMR, BNS, BP, BRCD, BRCM, BRKS, BTU, BWP, BX, BYI, C, CALL, CAT, CBI, CBOU, CDE, CELG, CEO, CERS, CGIX, CGR, CHK, CHL, CHMT, CJES, CLDT, CLF, CLMT, CLR, CMG, CMI, CMLP, CNAT, CNDO, CNP, CNQ, CNX, COF, COG, COH, COOL, COP, CORT, CPE, CPIX, CPSI, CRM, CROX, CRUS, CRZO, CSCO, CSX, CTCM, CVE, CVS, CVX, CXPO, CXS, CY, DAKT, DAN, DBC, DD, DDE, DECK, DENN, DG, DISH, DK, DNR, DO, DOW, DRH, DRIV, DSCO, DTLK, DTV, DUSA, DVAX, DVN, DVR, DWA, DXLG, E, EBAY, ECA, EDR, ELLI, ELY, EMC, END, ENDP, EOG, EOX, EPAM, EPAX, EPB, EPR, EQIX, EQM, EROC, ESIO, ESV, ETE, ETN, ETP, ETRM, EVEP, EWZ, EXK, EXLP, EXPE, EXXI, F, FANG, FB, FCH, FCX, FDX, FIG, FLL, FLY, FOLD, FOSL, FRD, FSC, FSII, FURX, FWLT, FXCM, GBX, GCOM, GE, GEF, GEOY, GERN, GES, GEVA, GFI, GILD, GLP, GLUU, GLW, GM, GNW, GOOG, GOOGL, GPOR, GPS, GS, GSK, GSM, GSS, GTATQ, GTE, HAL, HBM, HCBK, HCLP, HEP, HERO, HES, HFC, HIG, HL, HLF, HLX, HMA, HON, HOS, HP, HPQ, HPT, HRS, HRZN, HTA, HTGC, HURN, HZNP, IACI, IAG, IGTE, IMOS, INN, INT, INTC, INVN, IO, IPGP, IQNT, IRDM, IRET, IRT, ISRG, ITRI, ITT, IVAN, JAZZ, JDSU, JNJ, JNPR, JOY, JPM, KBH, KBR, KCG, KEG, KERX, KFY, KKR, KLAC, KLIC, KO, KOG, KONA, KR, KRG, KRO, LAD, LCI, LGCY, LIFE, LIME, LINE, LLL, LLNW, LLY, LMOS, LMT, LNCO, LNKD, LO, LOCO, LOW, LPRI, LSI, LUK, LULU, LVS, LXP, LYB, M, MANT, MCEP, MCHX, MCP, MDR, MDT, MELI, MEMP, MET, MHR, MITL, MMLP, MMP, MNK, MO, MOD, MOS, MPC, MPO, MPW, MRCY, MRGE, MRK, MRO, MRVL, MS, MSFT, MT, MTDR, MTOR, MTSN, MU, MUR, MXIM, MYL, MYRG, NAVB, NBL, NBR, NE, NEE, NEM, NEON, NFLX, NFX, NGLS, NGPC, NILE, NOG, NOK, NOV, NSC, NSPH, NTAP, NTSP, NUAN, NVAX, NVDA, NVS, NWY, NXPI, NYCB, NYX, OAS, OCN, OCZ, OHI, OIS, OKS, OPEN, OPLK, ORAN, ORCL, ORIG, ORLY, OUTR, OVTI, OXY, OZM, PAA, PAAS, PACD, PACR, PANW, PAYX, PBF, PBH, PBI, PBY, PCLN, PDH, PDLI, PDS, PEET, PEG, PES, PETM, PETS, PFE, PFMT, PGEM, PH, PM, PNG, PNK, PNRA, POM, POT, PRTA, PSX, PTEN, PULB, PVR, PWER, QCCO, QCOM, QLGC, QLTY, QRE, QUMU, R, RAIL, RAX, RCL, RDWR, REGN, RES, REXX, RF, RFMD, RIG, RIGL, RIO, RNN, ROC, ROSE, ROVI, RPRX, RRD, RSTI, RTEC, RTN, RUE, RUTH, RVBD, SAM, SARA, SBRA, SCLN, SCMR, SCO, SDRL, SEAC, SFY, SHOR, SIGA, SIMG, SIMO, SIRI, SKUL, SLB, SLCA, SM, SMCI, SN, SNH, SNY, SODA, SPLK, SPLS, SPN, SPPI, SPRT, SPY, SQNM, SSH, SSNLF, STI, STJ, STMP, STO, STT, STX, SUNE, SVU, SWFT, SWKS, SYNA, SYRG, T, TAL, TAP, TBT, TCAP, TDW, TEF, TER, TESO, TEVA, TEX, TGX, TICC, TIVO, TKR, TLLP, TOT, TPC, TPLM, TQNT, TRLG, TRN, TSLA, TSO, TST, TSYS, TTI, TWI, TWX, UA, UNH, UNIS, UPL, USB, V, VALE, VELTF, VICL, VLO, VMW, VNR, VOD, VRA, VXX, VZ, WAC, WAG, WDC, WEN, WFC, WFT, WHR, WIFI, WLL, WMT, WRES, XEC, XOM, XRX, YELP, YHOO, Z, ZAGG, ZEUS, ZIXI, ZLTQ, ZNGA
Latest  |  Highest rated
  • 2 Attractive Small-Cap Biotech Stocks On The Verge Of Breakouts [View article]
    It definitely is a bet the company move and I will await conference call after the bell to make judgement. Deal potentially provides ZGNX with cash equal to more than twice its enterprise value at these levels after today's sell-off. Will also watch if insiders buy the stock after announcement detailed.
    Mar 11, 2015. 10:13 AM | 1 Like Like |Link to Comment
  • Dynavax The Superior Player In Hepatitis B Vaccination [View article]
    Good piece. Agree DVAX very undervalued given prospects and has catalysts later in the year. Long DVAX.
    Mar 10, 2015. 11:56 AM | 3 Likes Like |Link to Comment
  • 2 Attractive Small-Cap Biotech Stocks On The Verge Of Breakouts [View article]
    Not a microcap I follow. Seems like it has similar business model to PGNX, which I do own and has done very well for me. Happy Hunting.
    Mar 10, 2015. 06:43 AM | Likes Like |Link to Comment
  • 2 Cheap Construction Plays [View article]
    Stock not acting well at moment but love the long term value at these levels.
    Mar 9, 2015. 09:40 AM | 1 Like Like |Link to Comment
  • 2 Biotechs Under $5 That Could Light Up In 2015 [View article]
    Still own NAVB. Like their recent licensing deal with Lymphoseek in Europe.
    Mar 8, 2015. 11:59 AM | Likes Like |Link to Comment
  • Navidea Pharmaceuticals: An Update On My $2 Biotech Lottery Ticket [View article]
    I would like color on that as well. Obviously some trials will need to take place to determine if Manocept technology can deliver an approved drug to treat various forms of cancer and other conditions without adverse affects.....whether that is some sort of a streamline process or the normal approval trajectory I do not know.
    Mar 7, 2015. 02:55 PM | 1 Like Like |Link to Comment
  • Acquisition Boosts AbbVie's Long Term Prospects [View article]
    Solid analogy, like it!
    Mar 7, 2015. 01:41 PM | 2 Likes Like |Link to Comment
  • Obama: "Extraordinarily dirty" oil extraction is reason for Keystone concern [View news story]
    No, but facts don't matter on this one. 44 is in the debt of the Steyers of the world as much as the press thinks the Republicans are doing the Koch brothers bidding. Pipeline is being held hostage by a small and far left bunch of environmental extremists. Canada should just build pipeline to Vancouver and ship to Asia, of course that would result in 30% to 40% more greenhouse emissions but why let the facts play a part in decision?
    Mar 7, 2015. 06:43 AM | 6 Likes Like |Link to Comment
  • Acquisition Boosts AbbVie's Long Term Prospects [View article]
    More around semantics. AbbVie does have a deep pipeline, purchasing Pharmacyclics gave it a newly approved drug to help its existing product portfolio and it now has 8 drugs that should easily do $100 million to $300 million per quarter in sales with Viekera Pak and Imbruvica capable of ramping up significantly over $500 million per quarter over time. Pipeline did not change much as result of purchase and remains deep.
    Mar 7, 2015. 06:38 AM | 1 Like Like |Link to Comment
  • Conatus Pharmaceuticals: A Potential Double Worth Consideration [View article]
    Market not taking CMO departure well but off from earlier lows. Really all depends on Emricasan does in trials so still an attractive high risk/high reward play within a well-diversified "shotgun investing" small cap biotech portfolio.
    Mar 6, 2015. 02:14 PM | 1 Like Like |Link to Comment
  • Lower Gasoline Prices Benefiting General Motors [View article]
    Still have position (much smaller than GM) in Ford as benefits from some of the same tailwinds and big dividend.
    Mar 5, 2015. 12:11 PM | 1 Like Like |Link to Comment
  • Case Builds For Owning Amgen [View article]
    Right on cue with the petty snark Mr. 8 followers
    Mar 5, 2015. 08:02 AM | 4 Likes Like |Link to Comment
  • AbbVie: Attractive Valuation, Growth Prospects & Yield [View article]
    Yep 58% in cash and they get blood cancer sales force which they need for upcoming products anyway.
    Mar 5, 2015. 07:05 AM | Likes Like |Link to Comment
  • DynaVax Technologies: The Small Cap Gem Focus Stock Of The Week [View article]
    Hopefully back on his meds.
    Mar 5, 2015. 06:00 AM | 1 Like Like |Link to Comment
  • $5 Or Less: 3 Small, Speculative Biotechs On The Move [View article]
    $AVEO making a big move here.
    Mar 4, 2015. 03:45 PM | Likes Like |Link to Comment
COMMENTS STATS
11,021 Comments
11,901 Likes